Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.8 mg) - tablet, film coated - excipient ingredients: iron oxide yellow; macrogol 6000; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; pregelatinised maize starch; purified talc - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: purified talc; macrogol 6000; lactose monohydrate; hypromellose; magnesium stearate; pregelatinised maize starch; iron oxide red; titanium dioxide - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: titanium dioxide; lactose monohydrate; triacetin; hypromellose; purified talc; magnesium stearate; iron oxide red - solifenacin dr.reddy's is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.75 mg) - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; iron oxide yellow; hypromellose; triacetin; titanium dioxide; lactose monohydrate - solifenacin dr.reddy's is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - acalabrutinib maleate monohydrate, quantity: 129 mg - tablet, film coated - excipient ingredients: mannitol; microcrystalline cellulose; hyprolose; sodium stearylfumarate; hypromellose; copovidone; titanium dioxide; macrogol 3350; medium chain triglycerides; iron oxide yellow; iron oxide red - calquence is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.,this indication is approved via the provisional approval pathway, based on overall response rate. full registration for this indication depends on verification and description of clinical benefit in confirmatory trials. calquence is indicated for the treatment of patients with chronic lymphocytic leukaemia (cll)/small lymphocytic lymphoma (sll).

Australia - English - Department of Health (Therapeutic Goods Administration)

swedish orphan biovitrum pty ltd - avatrombopag maleate, quantity: 23.6 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; crospovidone; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - doptelet is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.,doptelet is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (itp) who have had an insufficient response to a previous treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - lemborexant, quantity: 5 mg - tablet, film coated - excipient ingredients: hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; macrogol 8000; hypromellose; purified talc; iron oxide yellow - dayvigo is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance in accordance with latest diagnostic and statistical manual of mental disorders (dsm) criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - lemborexant, quantity: 10 mg - tablet, film coated - excipient ingredients: hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; macrogol 8000; hypromellose; purified talc; iron oxide yellow; iron oxide red - dayvigo is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance in accordance with latest diagnostic and statistical manual of mental disorders (dsm) criteria.

Malta - English - Medicines Authority

combino pharma (malta) ltd. hf60, hal far industrial estate, bbg07, hal far, malta - apixaban - film-coated tablet - apixaban 2.5 mg - antithrombotic agents

Malta - English - Medicines Authority

combino pharma (malta) ltd. hf60, hal far industrial estate, bbg07, hal far, malta - apixaban - film-coated tablet - apixaban 5 mg - antithrombotic agents